| Identification | Back Directory | [Name]
9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[3,2-f]quinolin-7(6H)-one | [CAS]
1196133-39-7 | [Synonyms]
LGD-3303
LGD-3303 white powder 99%
Manufacturers wholesale LGD3303 CAS NO.1196133-39-7
9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[3,2-f]quinolin-7(6H)-one
LGD3303,9-Chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[3,2-f]quinolin-7(6H)-one, | [EINECS(EC#)]
1592732-453-0 | [Molecular Formula]
C16H14ClF3N2O | [MDL Number]
MFCD17167063 | [MOL File]
1196133-39-7.mol | [Molecular Weight]
342.743 |
| Hazard Information | Back Directory | [Uses]
LGD-3303 is used in methods reducing mammographic breast density and/or breast cancer risk comprising the administration of an effective administration of an androgenic agent and an effective amt. of an aromatase inhibitor. LGD-3303 is also used in combination with anti-TWEAK antibodies for treating muscle atrophy. | [Biotechnological Applications]
LGD-3303 is a selective agonist for the androgen receptor, producing functional selectivity with effective dissociation of anabolic and androgenic effects, acting as a partial agonist for androgenic effects, but a full agonist for anabolic effects.It has been investigated as a possible treatment for osteoporosis, and was shown in animal studies to enhance the effectiveness of a bisphosphonate drug. |
|
|